PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren’s syndrome

OBJECTIVES: Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis patient’s serum. Our objective was to identify the targeted autoantigen and to evaluate di...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Rheum Dis
Autores principales: Fiorentino, David F., Presby, Matthew, Baer, Alan N., Petri, Michelle, Rieger, Kerri E., Soloski, Mark, Rosen, Antony, Mammen, Andrew L., Christopher-Stine, Lisa, Casciola-Rosen, Livia
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828328/
https://ncbi.nlm.nih.gov/pubmed/26253095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-207509
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares